FDA Approves First Heptavalent Botulism AntitoxinFDA Approves First Heptavalent Botulism Antitoxin

Derived from horse plasma and able to neutralize all 7 known botulinum nerve toxin serotypes, the antitoxin is stockpiled by federal authorities in case of a bioterrorist attack. FDA Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news